← Back to Search

Hemodialysis for Chronic Kidney Failure

N/A
Recruiting
Led By Tammy Sirich, MD
Research Sponsored by Palo Alto Veterans Institute for Research
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 4 weeks
Awards & highlights

Study Summary

This trial will see if patients with some kidney function will do better with two hemodialysis treatments a week, instead of the usual three.

Eligible Conditions
  • Chronic Kidney Failure
  • Hemodialysis

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~4 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and 4 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
QOL: KDQOL36
Secondary outcome measures
Cognition
Solute Concentration
Symptom

Trial Design

2Treatment groups
Experimental Treatment
Group I: Twice weekly hemodialysisExperimental Treatment1 Intervention
Participants will undergo hemodialysis twice per week.
Group II: Thrice weekly hemodialysisExperimental Treatment1 Intervention
Participants will undergo hemodialysis three times per week.

Find a Location

Who is running the clinical trial?

Palo Alto Veterans Institute for ResearchLead Sponsor
52 Previous Clinical Trials
7,855 Total Patients Enrolled
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)NIH
2,338 Previous Clinical Trials
4,319,429 Total Patients Enrolled
Tammy Sirich, MDPrincipal Investigator - Stanford/VA Palo Alto Health Care System
Palo Alto Veterans Institute for Research

Media Library

Twice weekly hemodialysis Clinical Trial Eligibility Overview. Trial Name: NCT03874117 — N/A
Chronic Kidney Failure Research Study Groups: Twice weekly hemodialysis, Thrice weekly hemodialysis
Chronic Kidney Failure Clinical Trial 2023: Twice weekly hemodialysis Highlights & Side Effects. Trial Name: NCT03874117 — N/A
Twice weekly hemodialysis 2023 Treatment Timeline for Medical Study. Trial Name: NCT03874117 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are participants being recruited for this trial at present?

"As per clinicaltrials.gov, this research project is currently in search of participants. It was first posted on July 1st 2018 and has received its most recent update on September 29th 2022."

Answered by AI

How can I become involved in this clinical research endeavor?

"This clinical trial seeks to enrol 50 individuals between the ages of 18 and 85 who are suffering from chronic kidney failure. It is imperative that potential participants possess stable dialysis capabilities as well as provide their consent for participation in this study."

Answered by AI

How many participants are currently taking part in this clinical research?

"Affirmative. Clinicaltrials.gov confirms that this investigation is presently recruiting participants, with the original posting being on 7/1/2018 and most recent edit occurring on 9/29/2022. There are 50 slots open across 3 medical sites for potential enrollees."

Answered by AI

Does the eligibility for this trial encompass those under 20 years old?

"As previously outlined in the eligibility requirements, this clinical trial is open to individuals between 18 and 85 years of age."

Answered by AI
~7 spots leftby Mar 2025